the invention belongs to the field of biotechnology and medicine, in particular to new options. \u0445\u0438\u043c\u0435\u0440\u043d\u043e\u0433\u043e \u043f\u0435\u043f\u0442\u0438\u0434\u0430 comprising functional \u0444\u0440\u0430\u0433\u043c kent and transport sequence and functional fragment includes \u0430\u043c\u0438\u043d\u043e\u043a\u0438\u0441\u043b\u043e\u0442\u043d\u0443\u044e sequence selected from the group SEQ id no: 1 SEQ id no: 17as well as \u0433\u043e\u043c\u043e\u043b\u043e\u0433\u0438\u0447\u043d\u044b\u0445 at 60% or more of sequences as well as the functional \u043f\u0435\u043f\u0442\u0438\u0434\u0443 with \u0430\u043d\u0442\u0438\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u043e\u0439 activity, the \u0430\u043c\u0438\u043d\u043e\u043a\u0438\u0441\u043b\u043e\u0442\u043d\u043e\u0439 p \u043e\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u043d\u043e\u0441\u0442\u044c\u044e, selected from the group SEQ id no: 1 SEQ id no: 17, as well as \u0433\u043e\u043c\u043e\u043b\u043e\u0433\u0438\u0447\u043d\u044b\u0445 at 60% or more sequences.the invention also relates to the use of the \u0445\u0438\u043c\u0435\u0440\u043d\u043e\u0433\u043e \u043f\u0435\u043f\u0442\u0438\u0434\u0430 for treatment of cancer, as well as pharmaceutical compositions, has the next \u0430\u043d\u0442\u0438\u043f\u0440\u043e\u043b\u0438\u0444\u0435\u0440\u0430\u0442\u0438\u0432\u043d\u043e\u0439 activity, and a method of treatment of cancer, including the introduction of the \u0445\u0438\u043c\u0435\u0440\u043d\u043e\u0433\u043e \u043f\u0435\u043f\u0442\u0438\u0434\u0430 was in need of a \u0435\u043d\u0438\u0438 \u043c\u043b\u0435\u043a\u043e\u043f\u0438\u0442\u0430\u044e\u0449\u0435\u043c\u0443.the invention provides a drug itself, effectively penetrating into target cells with high \u0446\u0438\u0442\u043e\u0441\u0442\u0430\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u043c and \u0446\u0438\u0442\u043e\u0442\u043e\u043a\u0441
